NPs Basic Information
|
Name |
Montagnuphilone D
|
| Molecular Formula | C21H24O10 | |
| IUPAC Name* |
3-[(3R,6S,7S)-6-(2,4-dihydroxy-6-methylbenzoyl)oxy-3,7-dihydroxy-7-methyl-8-oxo-1,4,5,6-tetrahydroisochromen-3-yl]propanoic acid
|
|
| SMILES |
CC1=CC(=CC(=C1C(=O)O[C@H]2CC3=C(CO[C@@](C3)(CCC(=O)O)O)C(=O)[C@@]2(C)O)O)O
|
|
| InChI |
InChI=1S/C21H24O10/c1-10-5-12(22)7-14(23)17(10)19(27)31-15-6-11-8-21(29,4-3-16(24)25)30-9-13(11)18(26)20(15,2)28/h5,7,15,22-23,28-29H,3-4,6,8-9H2,1-2H3,(H,24,25)/t15-,20-,21+/m0/s1
|
|
| InChIKey |
UGUYPVZDRVCYAD-ONGXBYRLSA-N
|
|
| Synonyms |
Montagnuphilone D
|
|
| CAS | NA | |
| PubChem CID | 139589653 | |
| ChEMBL ID | NA |
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 436.4 | ALogp: | 0.4 |
| HBD: | 5 | HBA: | 10 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 171.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 31 | QED Weighted: | 0.424 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -5.844 | MDCK Permeability: | 0.00010226 |
| Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.997 |
| Human Intestinal Absorption (HIA): | 0.718 | 20% Bioavailability (F20%): | 0.989 |
| 30% Bioavailability (F30%): | 0.994 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.101 | Plasma Protein Binding (PPB): | 83.08% |
| Volume Distribution (VD): | 0.351 | Fu: | 23.77% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.038 | CYP1A2-substrate: | 0.133 |
| CYP2C19-inhibitor: | 0.022 | CYP2C19-substrate: | 0.048 |
| CYP2C9-inhibitor: | 0.023 | CYP2C9-substrate: | 0.636 |
| CYP2D6-inhibitor: | 0.008 | CYP2D6-substrate: | 0.093 |
| CYP3A4-inhibitor: | 0.251 | CYP3A4-substrate: | 0.079 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 11.889 | Half-life (T1/2): | 0.811 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.052 |
| Drug-inuced Liver Injury (DILI): | 0.937 | AMES Toxicity: | 0.064 |
| Rat Oral Acute Toxicity: | 0.398 | Maximum Recommended Daily Dose: | 0.151 |
| Skin Sensitization: | 0.056 | Carcinogencity: | 0.905 |
| Eye Corrosion: | 0.005 | Eye Irritation: | 0.069 |
| Respiratory Toxicity: | 0.945 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003838 |  |
1.000 | D08NQZ |  |
0.256 | ||
| ENC003449 |  |
1.000 | D0R6RC |  |
0.252 | ||
| ENC003451 |  |
0.822 | D02GAC |  |
0.250 | ||
| ENC005503 |  |
0.590 | D05AFR |  |
0.248 | ||
| ENC003837 |  |
0.577 | D04VEJ |  |
0.245 | ||
| ENC002211 |  |
0.543 | D0J2NK |  |
0.243 | ||
| ENC002132 |  |
0.532 | D07MGA |  |
0.241 | ||
| ENC002726 |  |
0.529 | D0WY9N |  |
0.230 | ||
| ENC003448 |  |
0.500 | D03CEF |  |
0.227 | ||
| ENC003304 |  |
0.451 | D08LTU |  |
0.223 | ||